RGCC CAMBISeq is a comprehensive test which offers next-generation analysis on both DNA and RNA. By analyzing over 523 genes, this test predicts how your body will respond to immunotherapy, ensuring that your treatment is precisely tailored to your unique genetic makeup. The test result is personalized and targeted care that maximizes your chances of successful treatment outcomes.
RGCC CAMBISeq transforms your cancer treatment journey using your genetic blueprint.
Next-generation sequencing (NGS) is a powerful technology used in molecular biology to sequence DNA and RNA much more quickly and at a lower cost compared to traditional sequencing methods.
Specializing in identifying variants in over 523 genes, this test provides detailed genetic insights crucial for personalized cancer treatment.
The test results offer insights into the DNA makeup of a tumor which decides how a patient will respond to various forms of immunotherapy and cancer treatments.
RGCC CAMBISeq which helps to determine if a patient may respond well to immunotherapy or targeted therapy covers different types of cancers like lung, breast, colon, myeloid, sarcoma etc.,
The test applies to all types of cancer and is not just limited to the following.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
“With tests like CAMBISeq, which identifies more than 500 oncogenes and helps determine that any changes in these oncogenes could lead to cancer. Now with these advanced tools like Next Generation Sequencing, we can pinpoint the exact gene and its mutation that is responsible for causing cancer. “
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Decoding your genetic information, this test identifies the treatment option that aligns best with your unique needs. With insights from this test, clinicians can craft personalized therapies tailored to effectively target cancer, ultimately enhancing patient outcomes and quality of life.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
© 2025 Neeli Genetics. All Rights Reserved.